{
  "relevance_rule": {
    "rule_text": "Abstract with Client given keywords",
    "approach": "keywords",
    "key_concepts": {
      "keywords": [
        "Non-Small Cell Lung Cancer",
        "Pancreatic Ductal Adenocarcinoma",
        "Colorectal Cancer",
        "AMG-510",
        "Adagrasib",
        "LY-3537982",
        "Avutometinib",
        "GDC-6036",
        "JAB21822",
        "ELI-002",
        "RMC-6236",
        "RMC-6291",
        "Onvansertib",
        "MK-1084",
        "Zolbetuximab",
        "Pancreatic Cancer",
        "HBI-2438_",
        "Garsorasib",
        "BBO-8520",
        "FMC-376",
        "QTX3034",
        "QTX3046",
        "QTX3544",
        "RAS",
        "KRAS",
        "NRAS",
        "HRAS",
        "RAS-multi",
        "Pan-RAS",
        "RAS(ON)",
        "BTDX-4933",
        "RMC-9805",
        "G12",
        "Q61",
        "G13",
        "PF-07934040",
        "HRS-4642",
        "Quemliclustat",
        "ASP4396",
        "LY4066434",
        "RAS(on) Mutations",
        "RAS Wild-type",
        "Ivonescimab",
        "RAS(off)",
        "RAS(off) Mutations",
        "RO7673396",
        "Beta catenin",
        "SHOC2",
        "CHK1",
        "PAX8",
        "RAF1",
        "CypA",
        "PKN2",
        "PTK2",
        "FKBP",
        "STK7",
        "TP53",
        "sosimerasib",
        "D3S-001",
        "fulzerasib",
        "INCB161734",
        "TSN1611",
        "LY3962673",
        "AZD0022",
        "VS-7375",
        "JYP0015",
        "ERAS-0015",
        "ERAS-4001",
        "BI 3706674",
        "PF-07985045",
        "BGB-53038",
        "ALTA3263",
        "BBO-11818",
        "JAB-23E73",
        "AMG 410",
        "BBO-10203",
        "VVD-159642",
        "GDC-7035",
        "INCB186748",
        "AST-24081",
        "MYC",
        "ASP3082",
        "HBI-2438_",
        "D3S-001_",
        "BRSD-143",
        "Pan-KRAS",
        "KRAS-Multi",
        "G13C",
        "G13D",
        "G13R",
        "G13V",
        "G13P",
        "G13N",
        "G13S",
        "Q61H",
        "Q61L",
        "Q61R",
        "Q61K",
        "Q61P",
        "Q61E",
        "G12C",
        "G12V",
        "G12D",
        "G12A",
        "G12S",
        "G12F",
        "G12R",
        "G12L",
        "G12I",
        "G12E",
        "G12N",
        "PT886"
      ],
      "categories": [
        "Tumor Type",
        "Competitors",
        "Genotype",
        "Research"
      ],
      "contextual_concepts": []
    },
    "reasoning": "This rule is explicitly marked as the relevance filter and matches all abstracts containing any client-provided keywords."
  },
  "priority_rules": [
    {
      "priority": "High",
      "rule_text": "1. All abstracts with mentions of competitors\n2. Abstracts with tumor types in combination with client specified genotypes\n3. Abstracts mentioning K(RAS) mutant + tumor types.\n4. All abstracts with mentions of research keywords.\nExclude KRAS/RAS wild type abstracts",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "AMG-510",
          "Adagrasib",
          "LY-3537982",
          "Avutometinib",
          "GDC-6036",
          "JAB21822",
          "ELI-002",
          "RMC-6236",
          "RMC-6291",
          "Onvansertib",
          "MK-1084",
          "Zolbetuximab",
          "HBI-2438_",
          "Garsorasib",
          "BBO-8520",
          "FMC-376",
          "QTX3034",
          "QTX3046",
          "QTX3544",
          "BTDX-4933",
          "RMC-9805",
          "PF-07934040",
          "HRS-4642",
          "Quemliclustat",
          "ASP4396",
          "LY4066434",
          "Ivonescimab",
          "RO7673396",
          "sosimerasib",
          "D3S-001",
          "fulzerasib",
          "INCB161734",
          "TSN1611",
          "LY3962673",
          "AZD0022",
          "VS-7375",
          "JYP0015",
          "ERAS-0015",
          "ERAS-4001",
          "BI 3706674",
          "PF-07985045",
          "BGB-53038",
          "ALTA3263",
          "BBO-11818",
          "JAB-23E73",
          "AMG 410",
          "BBO-10203",
          "VVD-159642",
          "GDC-7035",
          "INCB186748",
          "AST-24081",
          "ASP3082",
          "HBI-2438_",
          "D3S-001_",
          "BRSD-143",
          "PT886",
          "Non-Small Cell Lung Cancer",
          "Pancreatic Ductal Adenocarcinoma",
          "Colorectal Cancer",
          "Pancreatic Cancer",
          "KRAS",
          "RAS",
          "NRAS",
          "HRAS",
          "RAS-multi",
          "Pan-RAS",
          "RAS(ON)",
          "RAS(on) Mutations",
          "Pan-KRAS",
          "KRAS-Multi",
          "G12",
          "Q61",
          "G13",
          "G13C",
          "G13D",
          "G13R",
          "G13V",
          "G13P",
          "G13N",
          "G13S",
          "Q61H",
          "Q61L",
          "Q61R",
          "Q61K",
          "Q61P",
          "Q61E",
          "G12C",
          "G12V",
          "G12D",
          "G12A",
          "G12S",
          "G12F",
          "G12R",
          "G12L",
          "G12I",
          "G12E",
          "G12N",
          "Beta catenin",
          "SHOC2",
          "CHK1",
          "PAX8",
          "RAF1",
          "CypA",
          "PKN2",
          "PTK2",
          "FKBP",
          "STK7",
          "TP53",
          "MYC"
        ],
        "categories": [
          "Competitors",
          "Tumor Type",
          "Genotype",
          "Research"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "KRAS wild type",
        "RAS wild type"
      ],
      "reasoning": "This rule is based on explicit keyword matching for competitors, tumor types with genotypes, K(RAS) mutant + tumor types, and research keywords, with exclusions for wild type genotypes."
    },
    {
      "priority": "Medium",
      "rule_text": "1. All abstracts with mentions of genotypes (excluding those with competitors, research keywords, or tumor types in combination with client specified genotypes)\n2. Abstracts mentioning (K)RAS wild type + tumor type.",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "KRAS",
          "RAS",
          "NRAS",
          "HRAS",
          "RAS-multi",
          "Pan-RAS",
          "RAS(ON)",
          "RAS(on) Mutations",
          "Pan-KRAS",
          "KRAS-Multi",
          "G12",
          "Q61",
          "G13",
          "G13C",
          "G13D",
          "G13R",
          "G13V",
          "G13P",
          "G13N",
          "G13S",
          "Q61H",
          "Q61L",
          "Q61R",
          "Q61K",
          "Q61P",
          "Q61E",
          "G12C",
          "G12V",
          "G12D",
          "G12A",
          "G12S",
          "G12F",
          "G12R",
          "G12L",
          "G12I",
          "G12E",
          "G12N",
          "RAS Wild-type",
          "KRAS wild type"
        ],
        "categories": [
          "Genotype"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "Competitors",
        "Research",
        "Tumor Type in combination with client specified genotypes"
      ],
      "reasoning": "This rule is based on keyword matching for genotypes and wild type mentions, but excludes abstracts already covered by the High priority rule (competitors, research keywords, or tumor type + genotype combinations)."
    },
    {
      "priority": "Low",
      "rule_text": "Abstracts with tumor types (excluding those with competitors, research keywords, or any genotype mentions)",
      "approach": "keywords",
      "key_concepts": {
        "keywords": [
          "Non-Small Cell Lung Cancer",
          "Pancreatic Ductal Adenocarcinoma",
          "Colorectal Cancer",
          "Pancreatic Cancer"
        ],
        "categories": [
          "Tumor Type"
        ],
        "contextual_concepts": []
      },
      "exclusions": [
        "Competitors",
        "Research",
        "Genotype"
      ],
      "reasoning": "This rule is based on keyword matching for tumor types only, and excludes any abstracts already covered by higher priority rules (competitors, research keywords, or genotype mentions)."
    }
  ]
}